
Sign up to save your podcasts
Or
Send us a text
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
4.8
7373 ratings
Send us a text
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
5,022 Listeners
2,338 Listeners
1,319 Listeners
485 Listeners
652 Listeners
765 Listeners
335 Listeners
1,118 Listeners
907 Listeners
196 Listeners
64 Listeners
100 Listeners
69 Listeners
111 Listeners
0 Listeners